Literature DB >> 21044894

Mouse serum paraoxonase-1 lactonase activity is specific for medium-chain length fatty acid lactones.

Philip W Connelly1, Clive M Picardo, Philip M Potter, John F Teiber, Graham F Maguire, Dominic S Ng.   

Abstract

Recent studies suggest that paraoxonase-1 (PON1), complexed with high-density lipoproteins, is the major lactonase in the circulation. Using 5-hydroxy eicosatetraenoate δ-lactone (5-HETEL) as the substrate, we observed lactonase activity in serum from Pon1-/- mice. However, 6-12 carbon fatty acid γ- and δ-lactones were not hydrolyzed in serum from Pon1-/- mice. Serum from both wild-type and Pon1-/- mice contained a lactonase activity towards 5-HETEL and 3-oxo-dodecanoyl-homoserine lactone that was resistant to inactivation by EDTA. This lactonase activity was sensitive to the serine esterase inhibitor phenyl methyl sulfonyl fluoride and co-eluted with carboxylesterase activity by size-exclusion chromatography. Analysis of serum from the Es1e mouse strain, which has a deficiency in the carboxylesterase, ES-1, proved that this activity was due to ES-1. PON1 activity predominated at early time points (30 s), whereas both PON1 and ES-1 contributed equally at later time points (15 min). When both PON1 and ES-1 were inhibited, 5-HETEL was stable in mouse serum. Thus, while long-chain fatty acid lactones are substrates for PON1, they can be hydrolyzed by ES-1 at neutral pH. In contrast, medium-chain length fatty acid lactones are stable in mouse serum in the absence of PON1, suggesting that PON1 plays a specific role in the metabolism of these compounds.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044894     DOI: 10.1016/j.bbalip.2010.10.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

Review 1.  Divergence and convergence in enzyme evolution: parallel evolution of paraoxonases from quorum-quenching lactonases.

Authors:  Mikael Elias; Dan S Tawfik
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  Paraoxonase-1 and clopidogrel efficacy.

Authors:  Jordi Camps; Jorge Joven; Bharti Mackness; Michael Mackness; Dan Tawfik; Dragomir Draganov; Lucio G Costa; György Paragh; Ildikó Seres; Sven Horke; Richard James; Antonio Hernández; Srinivasa Reddy; Diana Shih; Mohamed Navab; Daniel Rochu; Michael Aviram
Journal:  Nat Med       Date:  2011-09-07       Impact factor: 53.440

3.  ALOX5 gene variants affect eicosanoid production and response to fish oil supplementation.

Authors:  Charles B Stephensen; Patrice Armstrong; John W Newman; Theresa L Pedersen; Jillian Legault; Gertrud U Schuster; Darshan Kelley; Susanna Vikman; Jaana Hartiala; Rami Nassir; Michael F Seldin; Hooman Allayee
Journal:  J Lipid Res       Date:  2011-02-04       Impact factor: 5.922

4.  The evolutionary origins of detoxifying enzymes: the mammalian serum paraoxonases (PONs) relate to bacterial homoserine lactonases.

Authors:  Hagit Bar-Rogovsky; Adrian Hugenmatter; Dan S Tawfik
Journal:  J Biol Chem       Date:  2013-06-20       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.